Abstract
Background: Since the introduction of the TME (Total Mesorectal Excision) by Heald RJ in 1988 it has become an accepted and paramount approach to treat a rectal cancer. Utilization of laparascopy, in the last two decades, has gradually been recognized as a golden standard, given the reduction in overall complications, length of stay and in the same time a similar oncological outcome. Unfortunately, an anastomotic leak is still a valid and vast issue regarding the low and ultra-low colorectal resections. There are known, well-established risk factors such as male gender, narrow pelvis, obesity, diabetes, duration of surgery and field visualization. To treat the low rectal tumors in those patients a novel technic, presented by A. Lacy in 2010, TaTME (Transanal Total Mesorectal Excision) was successfully introduced, which in comparison to open/laparoscopic low anterior resection seems to have some advantages.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
